<?xml version="1.0" encoding="UTF-8"?>
<p>Lamivudine is active against FIV 
 <italic>in vitro</italic> [
 <xref rid="B3-vetsci-02-00456" ref-type="bibr">3</xref>,
 <xref rid="B20-vetsci-02-00456" ref-type="bibr">20</xref>,
 <xref rid="B21-vetsci-02-00456" ref-type="bibr">21</xref>,
 <xref rid="B23-vetsci-02-00456" ref-type="bibr">23</xref>,
 <xref rid="B38-vetsci-02-00456" ref-type="bibr">38</xref>,
 <xref rid="B41-vetsci-02-00456" ref-type="bibr">41</xref>]. A combination of zidovudine and lamivudine had synergistic anti-FIV activities in cell cultures [
 <xref rid="B41-vetsci-02-00456" ref-type="bibr">41</xref>]. FIV mutants resistant to lamivudine and containing a point mutation in the RT gene were selected 
 <italic>in vitro</italic> and showed cross resistance to zidovudine [
 <xref rid="B23-vetsci-02-00456" ref-type="bibr">23</xref>]. 
</p>
